229 related articles for article (PubMed ID: 10339596)
1. p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice.
Park MS; Rosai J; Nguyen HT; Capodieci P; Cordon-Cardo C; Koff A
Proc Natl Acad Sci U S A; 1999 May; 96(11):6382-7. PubMed ID: 10339596
[TBL] [Abstract][Full Text] [Related]
2. p27 deficiency desensitizes Rb-/- cells to signals that trigger apoptosis during pituitary tumor development.
Carneiro C; Jiao MS; Hu M; Shaffer D; Park M; Pandolfi PP; Cordon-Cardo C; Koff A
Oncogene; 2003 Jan; 22(3):361-9. PubMed ID: 12545157
[TBL] [Abstract][Full Text] [Related]
3. p27Kip1-deficient mice exhibit accelerated growth hormone-releasing hormone (GHRH)-induced somatotrope proliferation and adenoma formation.
Teixeira LT; Kiyokawa H; Peng XD; Christov KT; Frohman LA; Kineman RD
Oncogene; 2000 Apr; 19(15):1875-84. PubMed ID: 10773877
[TBL] [Abstract][Full Text] [Related]
4. CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis.
Franklin DS; Godfrey VL; Lee H; Kovalev GI; Schoonhoven R; Chen-Kiang S; Su L; Xiong Y
Genes Dev; 1998 Sep; 12(18):2899-911. PubMed ID: 9744866
[TBL] [Abstract][Full Text] [Related]
5. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.
Nakayama K; Ishida N; Shirane M; Inomata A; Inoue T; Shishido N; Horii I; Loh DY; Nakayama K
Cell; 1996 May; 85(5):707-20. PubMed ID: 8646779
[TBL] [Abstract][Full Text] [Related]
6. Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors.
Takeuchi S; Koeffler HP; Hinton DR; Miyoshi I; Melmed S; Shimon I
J Endocrinol; 1998 May; 157(2):337-41. PubMed ID: 9659297
[TBL] [Abstract][Full Text] [Related]
7. Id2 mediates tumor initiation, proliferation, and angiogenesis in Rb mutant mice.
Lasorella A; Rothschild G; Yokota Y; Russell RG; Iavarone A
Mol Cell Biol; 2005 May; 25(9):3563-74. PubMed ID: 15831462
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression levels of the cell-cycle inhibitor p27Kip1 in human pituitary adenomas.
Bamberger CM; Fehn M; Bamberger AM; Lüdecke DK; Beil FU; Saeger W; Schulte HM
Eur J Endocrinol; 1999 Mar; 140(3):250-5. PubMed ID: 10216521
[TBL] [Abstract][Full Text] [Related]
9. Substituting threonine 187 with alanine in p27Kip1 prevents pituitary tumorigenesis by two-hit loss of Rb1 and enhances humoral immunity in old age.
Zhao H; Bauzon F; Bi E; Yu JJ; Fu H; Lu Z; Cui J; Jeon H; Zang X; Ye BH; Zhu L
J Biol Chem; 2015 Feb; 290(9):5797-809. PubMed ID: 25583987
[TBL] [Abstract][Full Text] [Related]
10. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice.
Fero ML; Rivkin M; Tasch M; Porter P; Carow CE; Firpo E; Polyak K; Tsai LH; Broudy V; Perlmutter RM; Kaushansky K; Roberts JM
Cell; 1996 May; 85(5):733-44. PubMed ID: 8646781
[TBL] [Abstract][Full Text] [Related]
11. Cyclin-dependent kinase inhibitor p27Kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma.
Gillett CE; Smith P; Peters G; Lu X; Barnes DM
J Pathol; 1999 Jan; 187(2):200-6. PubMed ID: 10365095
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest.
Srethapakdi M; Liu F; Tavorath R; Rosen N
Cancer Res; 2000 Jul; 60(14):3940-6. PubMed ID: 10919672
[TBL] [Abstract][Full Text] [Related]
15. Switching of melanocyte pigmentation associated with pituitary pars intermedia tumors in Rb+/- and p27-/- female mice with yellow pelage.
Smith AP; Henze M; Osborn KG; Lee JA; Bortner DM; Rosenberg MP; Reed SI
Comp Med; 2003 Feb; 53(1):75-80. PubMed ID: 12625510
[TBL] [Abstract][Full Text] [Related]
16. In vivo significance of the G2 restriction point.
Foijer F; Delzenne-Goette E; Dekker M; Te Riele H
Cancer Res; 2007 Oct; 67(19):9244-7. PubMed ID: 17909031
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Cdk4 activity enhances translation of p27kip1 in quiescent Rb-negative cells.
González T; Seoane M; Caamaño P; Viñuela J; Domínguez F; Zalvide J
J Biol Chem; 2003 Apr; 278(15):12688-95. PubMed ID: 12566456
[TBL] [Abstract][Full Text] [Related]
18. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
[TBL] [Abstract][Full Text] [Related]
19. Genetic evidence for the interactions of cyclin D1 and p27(Kip1) in mice.
Tong W; Pollard JW
Mol Cell Biol; 2001 Feb; 21(4):1319-28. PubMed ID: 11158317
[TBL] [Abstract][Full Text] [Related]
20. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]